Post-Market Movers for Dec. 29: XNPT, RPRX, ACN Higher; CVEO, JST Lower

Civeo

- -28% - Civeo Affirms Q4 Outlook; Will Suspend Qtr. Dividend; Sees Q1 Sales $160.0M-175.0M vs $228.0M Est; Sees FY2015 Sales $540.0M-600.0M; Civeo Expecting Q1'15 EBITDA $45-$55M, FY15 EBITDA $135-$160M. XenoPort

- +16% - CNBC's Fast Money ‏@CNBCFastMoney Tweet: RBC's Michael Yee says Xenoport is his under the radar play for 2015 $XNPTDetails Repros

- +7% - Initiates Two Phase 2B Uterine Fibroid Studies. Expecting dossier to be filed by end of Q1, sees EU dossier submitted by Q1'16. Jinpan Int'l

- -5% - Reports Termination of Go-Private Deal Accenture

- +1.4% - wins five-year contract for healthcare.gov work.